Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study
出版年份 2020 全文链接
标题
Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-22
DOI
10.1007/s00228-020-02897-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk factors associated with the incidence and time to onset of lapatinib-induced hepatotoxicity
- (2019) Jin Young Moon et al. BREAST CANCER RESEARCH AND TREATMENT
- Factors Influencing Imatinib-Induced Hepatotoxicity
- (2019) Ji Min Han et al. Cancer Research and Treatment
- Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity
- (2018) Yoon Hee Park et al. ANTI-CANCER DRUGS
- Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study
- (2018) Min Kyoung Kim et al. BMC CANCER
- Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients
- (2018) Dasom Jung et al. MEDICAL ONCOLOGY
- Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity
- (2017) Soyeon Cho et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis
- (2017) Franziska Paech et al. Frontiers in Pharmacology
- The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials
- (2015) Gita Thanarajasingam et al. JNCI-Journal of the National Cancer Institute
- The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials
- (2015) Gita Thanarajasingam et al. JNCI-Journal of the National Cancer Institute
- The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia
- (2013) J. R. Veatch et al. BLOOD
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicators of Efficacy
- (2013) Devron R. Shah et al. DRUG SAFETY
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence
- (2012) Yi Ling Teo et al. BREAST CANCER RESEARCH AND TREATMENT
- Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
- (2012) N R Budha et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
- (2012) Ji-Youn Han et al. JOURNAL OF CLINICAL ONCOLOGY
- Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials
- (2011) Fabio A.B. Schutz et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metabolism considerations for kinase inhibitors in cancer treatment
- (2010) Derek R Duckett et al. Expert Opinion on Drug Metabolism & Toxicology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Very important pharmacogene summary
- (2010) Laura M. Hodges et al. Pharmacogenetics and Genomics
- Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects
- (2009) Deborah A. Smith et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Unintended Hepatic Adverse Events Associated with Cancer Chemotherapy
- (2009) John R. Senior TOXICOLOGIC PATHOLOGY
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More